Afreximbank’s African Medical Centre of Excellence wins Best Health Deal Award
The award recognises the AMCE as the most significant health-related transaction across the EMEA region
This award is a testament to the hard work and many hours of toiling by the multi-faceted and creative teams working on this highly impactive project
The African Medical Centre of Excellence (AMCE), under development by the African Export-Import Bank (Afreximbank) (www.Afreximbank.com) in Abuja, Nigeria, has received the award for the Best Health Deal in the Europe, Middle East, and Africa (EMEA) region.
The award, presented at the 15th Annual EMEA Finance Achievement and Project Awards Charity Dinner in London on 7th June, recognises the AMCE as the most significant health-related transaction across the EMEA region.
The EMEA Finance Achievement Awards recognize the achievements of the best banks and the most impactful deals and transactions across Europe, the Middle East and Africa Region.
Mrs. Gwen Mwaba, Afreximbank's Director & Global Head, Trade Finance who received the award on behalf of Afreximbank, noted that the AMCE project was being implemented with Kings College Hospital (KCH), London, as the clinical and technical partners and that a KCH team, which recently concluded a visit to the project site, had been “overwhelmingly impressed with the pace of progress”.
The AMCE, scheduled for commissioning in the first quarter of 2025, is being developed as a state-of-the-art hospital that will set the stage for advanced and wide-reaching healthcare in Nigeria and Africa. It is envisioned as a 500-bed secondary and tertiary healthcare institution offering a wide range of services and specializations.
It will offer a broad spectrum of care services, including oncology, cardiology, haematology, and general healthcare, in addition to providing the full range of medical services, including diagnostics, treatment, nuclear medicine, surgery and post-surgical care. The AMCE will also have supplementary components, such as a pharmaceuticals section, retail outlets and malls, academic and research centres, and hospitality and residential units.
Oluranti Doherty, Director Export Development commented: “this award is a testament to the hard work and many hours of toiling by the multi-faceted and creative teams working on this highly impactive project. Our goal, as Afreximbank is to revolutionize the healthcare landscape in the West African region, to begin with, and to the entire Africa region. Congratulations to all the teams involved.”
Brian Deaver, CEO, AMCE commented “this award clearly demonstrates what lies ahead for the AMCE – a new dawn in provision of best in class, globally recognized quality healthcare and clinical services in Africa, in support of Afreximbank’s leadership in trade and trade facilitation in Africa. My team and I are geared and excited to take up this challenge”.
Distributed by APO Group on behalf of Afreximbank.
Follow us on:
Twitter: https://apo-opa.info/41qI9VY
Facebook: https://apo-opa.info/3MGRNQi
LinkedIn: https://apo-opa.info/3KBxMYQ
Instagram: https://apo-opa.info/3UA1jH1
About Afreximbank:
African Export-Import Bank (Afreximbank) is a Pan-African multilateral financial institution mandated to finance and promote intra-and extra-African trade. For 30 years, the Bank has been deploying innovative structures to deliver financing solutions that support the transformation of the structure of Africa’s trade, accelerating industrialization and intra-regional trade, thereby boosting economic expansion in Africa. A stalwart supporter of the African Continental Free Trade Agreement (AfCFTA), Afreximbank has launched a Pan-African Payment and Settlement System (PAPSS) that was adopted by the African Union (AU) as the payment and settlement platform to underpin the implementation of the AfCFTA. Working with the AfCFTA Secretariat and the AU, the Bank is setting up a US$10 billion Adjustment Fund to support countries to effectively participate in the AfCFTA. At the end of 2022, Afreximbank’s total assets and guarantees stood at over US$31 billion, and its shareholder funds amounted to US$5.2 billion. The Bank disbursed more than US$86 billion between 2016 and 2022. Afreximbank has investment grade ratings assigned by GCR (international scale) (A), Moody’s (Baa1), Japan Credit Rating Agency (JCR) (A-) and Fitch (BBB). Afreximbank has evolved into a group entity comprising the Bank, its impact fund subsidiary called the Fund for Export Development Africa (FEDA), and its insurance management subsidiary, AfrexInsure, (together, “the Group”). For more information, visit: www.Afreximbank.com